These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16990632)

  • 1. Acute renal failure associated with inhaled tobramycin.
    Cannella CA; Wilkinson ST
    Am J Health Syst Pharm; 2006 Oct; 63(19):1858-61. PubMed ID: 16990632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute renal failure associated with use of inhaled tobramycin for treatment of chronic airway colonization with Pseudomonas aeruginosa.
    Izquierdo MJ; Gomez-Alamillo C; Ortiz F; Calabia ER; Ruiz JC; de Francisco AL; Arias M
    Clin Nephrol; 2006 Dec; 66(6):464-7. PubMed ID: 17176920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
    LeCleir LK; Pettit RS
    Pediatr Pulmonol; 2017 Aug; 52(8):1000-1005. PubMed ID: 28440913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vestibular toxicity due to inhaled tobramycin in a patient with renal insufficiency.
    Edson RS; Brey RH; McDonald TJ; Terrell CL; McCarthy JT; Thibert JM
    Mayo Clin Proc; 2004 Sep; 79(9):1185-91. PubMed ID: 15357042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vestibulotoxicity in a patient without renal failure after inhaled tobramycin.
    Kaufman AC; Eliades SJ
    Am J Otolaryngol; 2019; 40(3):456-458. PubMed ID: 30910434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.
    Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM
    Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
    Chuchalin A; Csiszér E; Gyurkovics K; Bartnicka MT; Sands D; Kapranov N; Varoli G; Monici Preti PA; Mazurek H
    Paediatr Drugs; 2007; 9 Suppl 1():21-31. PubMed ID: 17536872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient.
    Ahya VN; Doyle AM; Mendez JD; Lipson DA; Christie JD; Blumberg EA; Pochettino A; Nelson L; Bloom RD; Kotloff RM
    J Heart Lung Transplant; 2005 Jul; 24(7):932-5. PubMed ID: 15982625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobramycin-induced hepatotoxicity.
    Nisly SA; Ray SM; Moye RA
    Ann Pharmacother; 2007 Dec; 41(12):2061-5. PubMed ID: 17956959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
    N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
    Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL
    Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients.
    van Koningsbruggen-Rietschel S; Heuer HE; Merkel N; Posselt HG; Staab D; Sieder C; Ziegler J; Krippner F; Rietschel E
    J Antimicrob Chemother; 2016 Mar; 71(3):711-7. PubMed ID: 26626719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem.
    Fichtenbaum CJ; Smith MJ
    Clin Infect Dis; 1992 Jan; 14(1):353-4. PubMed ID: 1571451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Cheer SM; Waugh J; Noble S
    Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Colistin Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection Using a Rapid Method for Determination of Colistin in Plasma: Usefulness of Therapeutic Drug Monitoring.
    Yamada T; Ishiguro N; Oku K; Higuchi I; Nakagawa I; Noguchi A; Yasuda S; Fukumoto T; Iwasaki S; Akizawa K; Furugen A; Yamaguchi H; Iseki K
    Biol Pharm Bull; 2015; 38(9):1430-3. PubMed ID: 26155936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe use of meropenem in a patient with a possible nonimmediate allergy to imipenem.
    Lakhal K; Lortat-Jacob B; Neukirch C; Pajot O; Wolff M
    Pharmacotherapy; 2007 Sep; 27(9):1334-8. PubMed ID: 17723087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized tobramycin for Pseudomonas aeruginosa ventilator-associated pneumonia in patients with acute respiratory distress syndrome.
    Migiyama Y; Hirosako S; Tokunaga K; Migiyama E; Tashiro T; Sagishima K; Kamohara H; Kinoshita Y; Kohrogi H
    Pulm Pharmacol Ther; 2017 Aug; 45():142-147. PubMed ID: 28450200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.